Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study
- PMID: 27150682
- DOI: 10.1016/j.jacc.2016.01.037
Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study
Abstract
Background: Few studies have evaluated out-of-office blood pressure (BP) measurements as predictors of coronary artery disease (CAD) events.
Objectives: The aim of this study was to determine morning home blood pressure (HBP) as a predictor of CAD events.
Methods: Using data from the HONEST (Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure) study, we investigated the relationship between morning HBP and incidence of stroke and CAD events.
Results: In 21,591 treated hypertensive patients (mean age 64.9 years; mean follow-up 2.02 years), 127 stroke events (2.92 per 1,000 patient-years), and 121 CAD events (2.78 per 1,000 patient-years) occurred. The incidence of stroke events was significantly higher in patients with morning home systolic blood pressure (HSBP) ≥145 mm Hg compared with <125 mm Hg, and in patients with clinic systolic blood pressure (CSBP) ≥150 mm Hg compared with <130 mm Hg. Hazard ratios (HRs) were 6.01 (95% confidence interval [CI]: 2.85 to 12.68) between patients with morning HSBP ≥155 mm Hg and those with morning HSBP <125 mm Hg and 5.82 (95% CI: 3.17 to 10.67) between patients with CSBP ≥160 mm Hg and those with CSBP <130 mm Hg; morning HSBP predicted stroke events similarly to CSBP. Incidence of CAD events was significantly higher in patients with morning HSBP ≥145 mm Hg compared with <125 mm Hg and in patients with CSBP ≥160 mm Hg compared with <130 mm Hg. The HR for morning HSBP ≥155 mm Hg was 6.24 (95% CI: 2.82 to 13.84) and for CSBP ≥160 mm Hg was 3.51 (95% CI: 1.71 to 7.20); therefore, compared with morning HSBP, CSBP may underestimate CAD risk. Goodness-of-fit analysis showed that morning HSBP predicted CAD events more strongly than CSBP.
Conclusions: Morning HBP is a strong predictor of future CAD and stroke events, and may be superior to clinic BP in this regard. There does not appear to be a J-curve in the relationship between morning HBP and stroke or CAD events. (Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure Study [HONEST]; UMIN000002567).
Keywords: home blood pressure monitoring; hypertension; morning blood pressure; stroke.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Home Blood Pressure-Guided Antihypertensive Therapy Requires a Randomized Trial.J Am Coll Cardiol. 2016 Apr 5;67(13):1528-1530. doi: 10.1016/j.jacc.2016.02.017. J Am Coll Cardiol. 2016. PMID: 27150683 No abstract available.
Similar articles
-
Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.Hypertension. 2014 Nov;64(5):989-96. doi: 10.1161/HYPERTENSIONAHA.114.04262. Epub 2014 Aug 25. Hypertension. 2014. PMID: 25156169
-
Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study.J Clin Hypertens (Greenwich). 2014 Jun;16(6):442-50. doi: 10.1111/jch.12323. Epub 2014 Apr 25. J Clin Hypertens (Greenwich). 2014. PMID: 24766515 Free PMC article.
-
Morning Home Blood Pressure and Cardiovascular Events in a Japanese General Practice Population Over 80 Years Old: The J-HOP Study.Am J Hypertens. 2018 Oct 15;31(11):1190-1196. doi: 10.1093/ajh/hpy116. Am J Hypertens. 2018. PMID: 30188989
-
Perfect 24-h management of hypertension: clinical relevance and perspectives.J Hum Hypertens. 2017 Apr;31(4):231-243. doi: 10.1038/jhh.2016.65. Epub 2016 Sep 8. J Hum Hypertens. 2017. PMID: 27604658 Review.
-
Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension.J Hypertens. 2014 Dec;32(12):2332-40; discussion 2340. doi: 10.1097/HJH.0000000000000355. J Hypertens. 2014. PMID: 25333682 Review.
Cited by
-
Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study.Hypertens Res. 2024 Oct 28. doi: 10.1038/s41440-024-01954-7. Online ahead of print. Hypertens Res. 2024. PMID: 39463432
-
Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker.Hypertens Res. 2024 Oct 12. doi: 10.1038/s41440-024-01887-1. Online ahead of print. Hypertens Res. 2024. PMID: 39394512
-
The need for a personalized "implementation hypertension" strategy to facilitate the implementation of the new European Society of Hypertension (2023), European Society of Cardiology (2024) and the upcoming Japanese Society of Hypertension (2025) hypertension guidelines in clinical practice.Hypertens Res. 2024 Oct 7. doi: 10.1038/s41440-024-01927-w. Online ahead of print. Hypertens Res. 2024. PMID: 39375511 No abstract available.
-
Peak nocturnal home blood pressure as an early and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP Nocturnal BP study.Hypertens Res. 2024 Sep 6. doi: 10.1038/s41440-024-01866-6. Online ahead of print. Hypertens Res. 2024. PMID: 39242824
-
What are the ideal metrics for assessing the quality of long-term stabilized "perfect" 24-h BP control after renal denervation?Hypertens Res. 2024 Oct;47(10):2644-2651. doi: 10.1038/s41440-024-01859-5. Epub 2024 Aug 28. Hypertens Res. 2024. PMID: 39191961 Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
